Women's Health M&A Advisory
For multi-physician OB/GYN practices, integrated women's health platforms, and groups with surgical specialization, IVF services, or comprehensive ancillaries. Women's health consolidation is led by established platforms with strong appetite for quality middle-market groups.
Speak with an advisor: (800) 815-0590How We Help Women's Health Sellers
Capital Partners' M&A framework is built around the specific dynamics of middle-market specialty practice transactions. The three engagement profiles below cover most of how women's health practice owners come to us.
Five to twenty-five physician practices with established delivery volume, surgical mix, and operational infrastructure. The institutional buyer market for women's health groups in this size range is well-developed.
Discuss your practice →OB/GYN groups with significant gynecologic surgery volume, surgical center ownership or affiliation, and minimally invasive specialization command premium valuations through the procedural revenue base.
Discuss your platform →Practices integrated with ultrasound imaging, lab services, IVF/reproductive endocrinology, urogynecology, and maternal-fetal medicine achieve diversified revenue profiles that institutional buyers value highly.
Discuss your group →Market Context
Women's health consolidation is led by established platforms including Unified Women's Healthcare, Axia Women's Health, and a growing field of regional platforms. The Pediatrix portfolio also includes meaningful women's health activity. Hospital systems remain active strategic buyers, particularly for groups with established delivery volume and referral relationships.
The Capital Partners Approach
Women's health platform buyers evaluate practices carefully on the basis of surgical specialization, ancillary revenue mix, payer relationships, and physician roster. Practices with differentiated capabilities — gynecologic surgery, IVF, urogynecology, maternal-fetal medicine — consistently command higher valuations than general OB/GYN practices.
The women's health buyer landscape includes both PE platforms and strategic acquirers (hospital systems), each with different evaluation frameworks and post-close models. A deliberate process surfaces the right buyer type for the specific practice, which materially affects both terms and post-close trajectory.
Valuation Drivers
Women's Health practice valuation is driven by a specific set of operational, clinical, and structural factors. Below are the elements buyers evaluate most carefully when developing valuation and offer terms.
Gynecologic surgery volume, including minimally invasive procedures, robotic-assisted surgery, and complex surgical cases, drives meaningful valuation premium over office-based OB practices.
Integrated fertility services represent high-margin cash-pay revenue. Practices with IVF programs achieve substantial valuation premiums through the high-revenue procedural mix.
Ultrasound imaging, lab services, urogynecology, maternal-fetal medicine, and pelvic floor services contribute meaningfully to total practice EBITDA. Ancillary depth is highly valued.
Commercial payer relationships, Medicare/Medicaid exposure, and managed care contract structure all factor into buyer evaluation. Payer mix significantly influences valuation.
Physician count, sub-specialty depth (general OB/GYN, GYN-only, MFM, REI, urogynecology), tenure, and post-close commitments all factor into buyer evaluation.
Market share in the metropolitan area, referral relationships with primary care, and competitive position with hospital systems influence valuation. Geographic strength matters.
Begin a Conversation
The most useful next step is a confidential conversation. We'll listen to your situation, give you a directional view of where your practice sits in the current market, and explain how a Capital Partners engagement would actually run. Every conversation begins under NDA.
(800) 815-0590